Clinical Biochemistry 2013-01-01

A multiplex assay to detect variations in the CYP2C9, VKORC1, CYP4F2 and APOE genes involved in acenocoumarol metabolism.

A M López-Parra, A M Borobia, C Baeza, E Arroyo-Pardo, A J Carcas

Index: Clin. Biochem. 46(1-2) , 167-9, (2013)

Full Text: HTML

Abstract

We have developed a genotyping system to determine the alleles of genes related to interindividual variability in acenocoumarol dosage requirements. This genotyping system is intended for routine clinical use and therefore it is essential that it be simple, fast and inexpensive.We developed a PCR multiplex SNaPshot reaction that targets 6 SNPs (single nucleotide polymorphisms) in CYP2C9, CYP4F2, VKORC1 and APOE genes, which are associated with acenocoumarol dose requirements.We tested the multiplex in 152 samples and found it to be 100% concordant with the results of other methods.We successfully produced a reliable multiplex system for simultaneously typing 6 SNPs. This system may be used as a model for accurate, simple and inexpensive genotyping of SNPs related to dose requirements. This information allows the prediction of drug efficiency in patients prior to treatment with acenocoumarol and the prevention of adverse drug reactions.Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.


Related Compounds

  • acenocoumarol
  • Menthyl isovalerat...

Related Articles:

A chiral separation strategy for acidic drugs in capillary electrochromatography using both chlorinated and nonchlorinated polysaccharide-based selectors.

2014-10-01

[Electrophoresis 35(19) , 2807-18, (2014)]

A rapid method for determination of 22 selected drugs in human urine by UHPLC/MS/MS for clinical application.

2014-01-01

[J. AOAC Int. 97(6) , 1526-37, (2015)]

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

2015-01-01

[J. Infect. Dis. 211(1) , 72-9, (2014)]

Interaction between ciclopirox and acenocoumarol.

2013-03-01

[Eur. J. Clin. Pharmacol. 69(3) , 727-8, (2013)]

Patients benefit from genetics-guided coumarin anticoagulant therapy.

2014-07-01

[Clin. Pharmacol. Ther. 96(1) , 15-7, (2014)]

More Articles...